epithalon what does it do Dosage: 10-Day Cycle & Schedule Epithalon (40mg vials) - Peptide
Description
Some patients may see longer-lasting results, but maintenance treatments are recommended to keep the hands youthful and smooth
There are no randomised trials and only observational studies with relatively small sample sizes are available, thus providing a low level of evidence
However, the pooled analysis did not show significantly lower disability progression: 12-week worsening of disability was 5.2% in the ublituximab group compared to 5.9% in the teriflunomide group
Manufactured under controlled production standards
